UR

Uma Ratna Rachakonda

Active Director Director DIN 06960958
DIN 06960958 First appointment Apr 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Uma Ratna Rachakonda

Data last updated:

Uma Ratna Rachakonda is a Director at Savita Biotech Private Limited (since 2015). The company operates in Pharma. Savita Biotech Private Limited reported revenue of ₹1.81 Cr (FY 2025).

DIN 06960958
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2015
Oldest Company Age 11 yrs
Largest company Savita Biotech Private Limited · ₹1.81 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Savita Biotech Private Limited U24100AP2015PTC096530
Director21 Apr 20152015₹1.81 Cr (FY 2025)Active

Board colleagues of Uma Ratna Rachakonda

Directorship timeline

Open interactive timeline →
Savita Biotech Private Limited
Premium access

Shareholding and investment profile for Uma Ratna Rachakonda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Ratna Rachakonda

Uma Ratna Rachakonda currently holds 1 directorship: Savita Biotech Private Limited (Director, since 21 Apr 2015, revenue ₹1.81 Cr (FY 2025)).

Uma Ratna Rachakonda was first appointed on 21 Apr 2015 as Director at Savita Biotech Private Limited.

The current boards of Uma Ratna Rachakonda's companies include Srimat Tirumala Pallerlamudi Lakshmi Narasimha Ravikanth (Savita Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available